PMC5394619_01
a PSA course after ipilimumab and radiotherapy for patient n 1 and n 2. b Bone scan at baseline and after treatment with ipilimumab and radiotherapy for patient n 1 and n 2. ANT = anterior, POST = posterior. c CT-scan for patient n 1 at baseline (left) and after 10 months (right)
40425_2017_232_Fig1_HTML.jpg
PMC5394619_02_40425_2017_232_Fig1_HTML.jpg
Fig1
Serum PSA is still undetectable at 52 months, without any clinical or radiological sign of cancer progression (Fig. 1).
Immune infiltration in archival prostate biopsies (CD3, CD8 and FOXP3 expression by immunohistochemistry)
40425_2017_232_Fig2_HTML.jpg
PMC5394619_01_40425_2017_232_Fig2_HTML.jpg
Fig2
FoxP3+ T cells (Fig. 2). FoxP3 staining was highly specific with nuclear staining found only in lymphocytes and not in tumor cells.
PMC5394619_02
a PSA course after ipilimumab and radiotherapy for patient n 1 and n 2. b Bone scan at baseline and after treatment with ipilimumab and radiotherapy for patient n 1 and n 2. ANT = anterior, POST = posterior. c CT-scan for patient n 1 at baseline (left) and after 10 months (right)
40425_2017_232_Fig1_HTML.jpg
PMC5394619_02_40425_2017_232_Fig1_HTML.jpg
Fig1
Serum PSA is still undetectable at 52 months, without any clinical or radiological sign of cancer progression (Fig. 1).